RECRUITING

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

Talk to us

Conditions

Autism Spectrum DisorderAutismIrritabilityCannabinoids

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This trial aims to study the efficacy and safety of cannabidivarin (CBDV) in children with ASD.

Official Title

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

Quick Facts

Study Start:2019-04-12
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03202303

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:5 Years to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Casara Ferretti, MS, MA
CONTACT
914-315-4236
casara.ferretti@einsteinmed.edu

Principal Investigator

Eric Hollander, MD
PRINCIPAL_INVESTIGATOR
Montefiore Medical Center/Albert Einstein College of Medicine

Study Locations (Sites)

Montefiore Medical Center
Bronx, New York, 10467
United States
New York University (NYU) Langone
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: Montefiore Medical Center

  • Eric Hollander, MD, PRINCIPAL_INVESTIGATOR, Montefiore Medical Center/Albert Einstein College of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-04-12
Study Completion Date2025-12

Study Record Updates

Study Start Date2019-04-12
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • Autism
  • Irritability
  • Cannabinoids

Additional Relevant MeSH Terms

  • Autism Spectrum Disorder